Scandinavian ChemoTech AB Class B(SE:NEEMS.B)
kr 2.09+0.03 (+1.46%)
SE:NEEMS.B
Scandinavian ChemoTech AB Class B financials statements
kr 2.09
At close:+0.03 (+1.46%)
Want to see SE:NEEMS.B full AI Analyst Report?
Scandinavian ChemoTech AB Class B (NEEMS.B) Income Statement
1 Followers
Scandinavian ChemoTech AB Class B Income Statement
Last quarter (Q1 2026), Scandinavian ChemoTech AB Class B's total revenue was kr2.80M, an increase of 13.19% from the same quarter last year. In Q1, Scandinavian ChemoTech AB Class B's net income was kr-1.57M. See Scandinavian ChemoTech AB Class B’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 12.29M | kr 6.57M | kr 2.82M | kr 473.00K | kr 49.00K | |
| kr -4.50M | kr 4.78M | kr 1.66M | kr -55.00K | kr 323.00K | |
| kr 1.80M | kr 17.57M | kr 21.89M | kr 20.86M | kr 19.94M | |
| Depreciation and Amortization | kr 1.97M | kr 163.00K | kr 109.00K | kr 41.00K | kr 42.00K |
| kr -4.33M | kr -12.38M | kr -19.58M | kr -20.81M | kr -17.03M | |
| kr -6.30M | kr -12.80M | kr -20.24M | kr -20.91M | kr -17.08M | |
| kr -1.75M | kr -921.00K | kr -854.00K | kr -1.83M | kr -666.00K | |
| kr -8.06M | kr -13.72M | kr -21.09M | kr -22.75M | kr -17.74M | |
| kr -8.06M | kr -13.72M | kr -21.09M | kr -22.75M | kr -17.74M | |
| Per Share Metrics | |||||
| Basic EPS | kr -0.34 | kr -0.59 | kr -1.50 | kr -2.28 | kr -2.05 |
| Diluted EPS | kr -0.34 | kr -0.59 | kr -1.50 | kr -2.28 | kr -2.05 |
| Weighted Average Shares Outstanding | 24.03M | 23.34M | 14.04M | 9.97M | 8.66M |
| Weighted Average Shares Outstanding (Diluted) | 24.03M | 23.34M | 14.04M | 9.97M | 8.66M |
Currency in SEK
